GICS Roundup: PD-1 Inhibitor Yields 100% Response Rate in dMMR Rectal Cancer
Plus: Promising activity in <em>BRAF</em>-mutant CRC, L-asparaginase drug falls short in pancreatic cancer
France General New York United States Memorial Sloan Kettering Cancer Center Svane Morris Hopital Beaujon
Source: medpagetoday.com